ZOMETAY Trademark

Trademark Overview

On Monday, August 20, 2001, a trademark application was filed for ZOMETAY with the United States Patent and Trademark Office. The USPTO has given the ZOMETAY trademark a serial number of 78080104. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 28, 2012. This trademark is owned by Novartis AG. The ZOMETAY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous, immune, musculoskeletal, cardiovascular, and respiratory systems, and for use in oncology

General Information

Serial Number78080104
Word MarkZOMETAY
Filing DateMonday, August 20, 2001
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 28, 2012
Registration Number3094842
Registration DateTuesday, May 23, 2006
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, August 27, 2002

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the central nervous, immune, musculoskeletal, cardiovascular, and respiratory systems, and for use in oncology

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 28, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH
Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events

Event DateEvent Description
Friday, December 28, 2012CANCELLED SEC. 8 (6-YR)
Saturday, June 20, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 23, 2006REGISTERED-PRINCIPAL REGISTER
Thursday, April 6, 20061(B) BASIS DELETED; PROCEED TO REGISTRATION
Saturday, November 19, 2005NOTICE OF ALLOWANCE CANCELLED
Wednesday, September 14, 2005TEAS DELETE 1(B) BASIS RECEIVED
Monday, May 23, 2005EXTENSION 5 GRANTED
Wednesday, May 4, 2005EXTENSION 5 FILED
Friday, May 6, 2005PAPER RECEIVED
Wednesday, May 4, 2005TEAS EXTENSION RECEIVED
Monday, January 24, 2005APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, December 19, 2004TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 6, 2004PAPER RECEIVED
Tuesday, November 16, 2004EXTENSION 4 GRANTED
Monday, November 8, 2004EXTENSION 4 FILED
Monday, November 8, 2004TEAS EXTENSION RECEIVED
Wednesday, June 2, 2004PAPER RECEIVED
Friday, May 7, 2004EXTENSION 3 GRANTED
Monday, May 3, 2004EXTENSION 3 FILED
Wednesday, May 5, 2004CASE FILE IN TICRS
Monday, May 3, 2004TEAS EXTENSION RECEIVED
Monday, April 26, 2004ASSIGNED TO EXAMINER
Monday, November 10, 2003EXTENSION 2 GRANTED
Thursday, October 30, 2003EXTENSION 2 FILED
Thursday, October 30, 2003TEAS EXTENSION RECEIVED
Friday, August 22, 2003EXTENSION 1 GRANTED
Friday, May 2, 2003EXTENSION 1 FILED
Thursday, May 1, 2003TEAS EXTENSION RECEIVED
Tuesday, November 19, 2002NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 27, 2002PUBLISHED FOR OPPOSITION
Wednesday, August 7, 2002NOTICE OF PUBLICATION
Monday, June 17, 2002SEC. 44(D) CLAIM DELETED
Thursday, June 13, 2002APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 10, 2002EXAMINERS AMENDMENT MAILED
Wednesday, April 24, 2002CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 24, 2002PAPER RECEIVED
Thursday, October 25, 2001LETTER OF SUSPENSION MAILED
Tuesday, October 23, 2001ASSIGNED TO EXAMINER

Related Keywords

zometay cardiovascular musculoskeletal respiratory systems oncology immune nervous treatment preparations diseases